Implementation of the patient version of the evidence-based (S3) guideline for psychosocial interventions for patients with severe mental illness (IMPPETUS): a cluster randomised controlled study

Not Applicable

• Conditions: F20-F29; F30-F39; Schizophrenia, schizotypal and delusional disorders; Mood [affective] disorders

• Registration Number: DRKS00017577
• Lead Sponsor: niversitätsklinikum Ulm, Klinik für Psychiatrie und Psychotherapie II

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-23
• Study Completion: 2021-10-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 535

Inclusion Criteria

Inpatients and day hospital patients; patients with schizophrenia, schizotypal and delusional disorders (ICD-10 F2x) or Mood [affective] disorders (ICD-10 F3x); disease duration of = 2 years; considerable consequences on activities of daily life (‘Global Assessment of Functioning’ (GAF) score = 60 and a ‘Health of the Nation Outcome Scales’ (HoNOS) Score of = 2 on one of the items of the subscale for symptomatic problems (item 6, 7, and 8) and a score of = 2 on each of the four items of the subscale for social problems (items 9, 10, 11, and 12) or a score of = 3 on at least one of these items (9, 10, 11, or 12)) // relatives of patients with mental disorders: both sexes, age >= 18 years

Exclusion Criteria

Patients and relatives who are not able to consent; Patients and relatives who are unable to understand answer the questions/study; Relatives when they are in inpatient or day hospital mental health care

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is the change of empowerment after 6 month, which will be measured using the 'empowerment in the process of psychiatric treatment of patients with affective and schizophrenia disorders (EPAS)' scale.